Neuland Laboratories Ltd (NEULANDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 229993, "name": "Neuland Labs.", "stock_name": "Neuland Labs.", "full_name": "Neuland Laboratories Ltd", "name_url": "stocks-analysis/neuland-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "12,000.00", "chg": 450.25, "chgp": "3.9%", "dir": 1, "prev_price": "11,549.75", "mcapval": "15,028.00 Cr", "mcap": "Small Cap", "scripcode": 524558, "symbol": "NEULANDLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE794A01010", "curr_date": "Mar 24", "curr_time": "", "bse_nse_vol": "30.1 k", "exc_status": "Active", "traded_date": "Mar 24, 2026", "traded_date_str": "2026 03 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Neuland Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3898294", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3898294.png", "date": "2026-03-18 10:11:11", "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Neuland Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3877795", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3877795.png", "date": "2026-03-07 10:10:38", "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Neuland Laboratories Falls 2.99%: 3 Key Technical and Fundamental Factors Driving the Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-falls-299-3-key-technical-and-fundamental-factors-driving-the-decline-3863179", "imagepath": "", "date": "2026-03-01 11:01:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Feb:</strong> Downgrade to Sell rating announced amid financial and technical weakness</p>\n <p><strong>18 Feb:</strong> Technical momentum shifts to sideways with mixed indicator signals</p>\n <p><strong>20 Feb:</strong> Mildly bearish technical shift amid market volatility and price decline</p>\n <p><strong>20 Feb:</strong> Week closes at Rs.12,654.10 (-2.99%) vs Sensex +0.39%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13,242.00</div></div>\n <div class=\"stat-item\"><div cla..." }, { "title": "Neuland Laboratories Gains 1.21%: 4 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-121-4-key-factors-driving-the-weeks-mixed-momentum-3862734", "imagepath": "", "date": "2026-02-28 17:08:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Intraday high surge of 7.89% to Rs.13,652.75</p>\n <p><strong>23 Feb:</strong> Formation of Death Cross signalling bearish trend</p>\n <p><strong>24 Feb:</strong> Downgrade to Strong Sell amid deteriorating fundamentals</p>\n <p><strong>24 Feb:</strong> Shift from mildly bearish to bearish technical trend</p>\n <p><strong>27 Feb:</strong> Week closes at Rs.12,806.85 (+1.21%) outperforming Sensex</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12,654.10</div></div>\n ..." }, { "title": "Neuland Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3852270", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_mojoScore_3852270.png", "date": "2026-02-24 08:08:08", "description": "Neuland Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 23 February 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical company’s Mojo Score has dropped to 28.0, signalling heightened caution for investors amid a challenging financial and market environment." }, { "title": "Neuland Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-3851957", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3851957.png", "date": "2026-02-24 08:01:09", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a strong day change of 7.89%, the stock’s technical parameters, including MACD, RSI, and moving averages, suggest caution for investors amid mixed signals and deteriorating momentum." }, { "title": "Neuland Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-3851786", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_dealthcross_3851786.png", "date": "2026-02-23 18:00:21", "description": "Neuland Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum amid challenging market conditions." }, { "title": "Neuland Laboratories Ltd Hits Intraday High with 7.5% Surge on 23 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-75-surge-on-23-feb-2026-3851743", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_priceRelatedfactors_3851743.png", "date": "2026-02-23 15:01:28", "description": "Neuland Laboratories Ltd recorded a robust intraday performance on 23 Feb 2026, surging to a day’s high of Rs 13,630, marking a 7.71% increase. This sharp uptick outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting a notable rebound after three consecutive days of decline." }, { "title": "Why is Neuland Laboratories Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-neuland-laboratories-ltd-fallingrising-3848979", "imagepath": "", "date": "2026-02-21 01:00:40", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Comparison</strong></p>\n<p>Neuland Laboratories has underperformed both its sector and the broader market in recent weeks. Over the past week, the stock declined by 2.99%, contrasting with the Sensex’s modest gain of 0.23%. The one-month performance further highlights this divergence, with the stock falling 6.82% while the benchmark rose 0.77%. Year-to-date, the stock has dropped 16.70%, significantly underperforming the Sensex’s 2.82% decline. Despite these short-term setbacks, the stock has delivered a robust 11.00% return over the last year, outpacing the Sensex’s 9.35% gain. However, this positive annual return masks underlying challenges that have emerged more recently.</p>\n<p>On the trading day of 20-Feb, the stock’s intraday low reached ₹12,557, rep..." } ], "total": 747, "sid": "229993", "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "23-Mar-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate", "datetime": "19-Mar-2026", "details": "Issue of Letter of Confirmation in lieu of Share Certificate(s) lost / misplaced", "source": "BSE" }, { "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate", "datetime": "12-Mar-2026", "details": "Intimation of Loss of Share Certificate(s)", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25", "dt": "2025-07-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14", "dt": "2014-08-13", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

16 Feb: Downgrade to Sell rating announced amid financial and technical weakness

18 Feb: Technical momentum shifts to sideways with mixed indicator signals

20 Feb: Mildly bearish technical shift amid market volatility and price decline

20 Feb: Week closes at Rs.12,654.10 (-2.99%) vs Sensex +0.39%

Week Open

Rs.13,242.00

Read full news article

Neuland Laboratories Gains 1.21%: 4 Key Factors Driving the Week’s Mixed Momentum

2026-02-28 17:08:42

Key Events This Week

23 Feb: Intraday high surge of 7.89% to Rs.13,652.75

23 Feb: Formation of Death Cross signalling bearish trend

24 Feb: Downgrade to Strong Sell amid deteriorating fundamentals

24 Feb: Shift from mildly bearish to bearish technical trend

27 Feb: Week closes at Rs.12,806.85 (+1.21%) outperforming Sensex

Week Open

Rs.12,654.10

...

Read full news article

Neuland Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals

2026-02-24 08:08:08

Neuland Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 23 February 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical company’s Mojo Score has dropped to 28.0, signalling heightened caution for investors amid a challenging financial and market environment.

Read full news article

Neuland Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals

2026-02-24 08:01:09

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a strong day change of 7.89%, the stock’s technical parameters, including MACD, RSI, and moving averages, suggest caution for investors amid mixed signals and deteriorating momentum.

Read full news article

Neuland Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-02-23 18:00:21

Neuland Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum amid challenging market conditions.

Read full news article

Neuland Laboratories Ltd Hits Intraday High with 7.5% Surge on 23 Feb 2026

2026-02-23 15:01:28

Neuland Laboratories Ltd recorded a robust intraday performance on 23 Feb 2026, surging to a day’s high of Rs 13,630, marking a 7.71% increase. This sharp uptick outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting a notable rebound after three consecutive days of decline.

Read full news article

Why is Neuland Laboratories Ltd falling/rising?

2026-02-21 01:00:40

Recent Price Performance and Market Comparison

Neuland Laboratories has underperformed both its sector and the broader market in recent weeks. Over the past week, the stock declined by 2.99%, contrasting with the Sensex’s modest gain of 0.23%. The one-month performance further highlights this divergence, with the stock falling 6.82% while the benchmark rose 0.77%. Year-to-date, the stock has dropped 16.70%, significantly underperforming the Sensex’s 2.82% decline. Despite these short-term setbacks, the stock has delivered a robust 11.00% return over the last year, outpacing the Sensex’s 9.35% gain. However, this positive annual return masks underlying challenges that have emerged more recently.

On the trading day of 20-Feb, the stock’s intraday low reached ₹12,557, rep...

Read full news article

View All News